The University of Nebraska, a University Affiliated Research Center designated by the Department of Defense, is proud to lead an effort to help the DOD develop therapeutics for the treatment of man-made threats that fail to achieve FDA approval due to the lack of interest by the pharmaceutical industry. The Nebraska Drug Development Pipeline is a partnership between the pharmaceutical industry, the federal government and the campuses of the University of Nebraska (NU) to develop needed drugs.
University of Nebraska
Drug Development To Keep Our Warfighters Safe
An Efficient, Accurate Process
The process for developing drugs is long and tedious, but the University of Nebraska has called upon its experts and partners to streamline and create efficiencies.
The Nebraska Drug Development Pipeline brings together the range of disciplines required for advancing potential new drugs to FDA approval, including medicinal chemistry, pharmacokinetics, drug metabolism, bioinformatics, microbiology, physiology, toxicology and computer science.
Radiation Exposure Treatment
The NU project for the Defense Health Agency (DHA), and in collaboration with Armed Forces Radiobiology Research Institute (AFRRI), has reached a second increment -- potentially awarding nearly $11 million in federal funding over the next five years. NU researchers will look for therapeutics candidates the U.S. military would need to protect troops from radiation in case of exposure, as in a nuclear accident or a nuclear weapons incident.
Photo from left: UNMC's Rebecca Oberley-Deegan, Ph.D., Ken Bayles, Ph.D., and David Berkowitz, Ph.D., of the University of Nebraska-Lincoln.Learn More
Respiratory Treatment for Exposure to Chemical and Biological Threats
The Defense Threat Reduction Agency is working with the University of Nebraska to investigate novel therapeutic, prophylactic and pretreatment approaches for respiratory recovery and exposure to chemical and biological threats.
From left: xxxx.Learn More
Leading FacilitiesThe University of Nebraska is uniquely positioned to create and nurture this type of pipeline as a result of its investment in facilities and technology over the past several decades, allowing it to handle the development of drug therapies efficiently on site.
Facility 1Brief Summary
Facility 2Brief Summary
Facility 3Brief Summary
Facility 4Brief Summary
XX subject matter experts from the University of Nebraska are currently involved in projects through the Nebraska Drug Development Pipeline. Here are the leads for each of the campuses involved.
Connect With Us
We are actively seeking partners, colleagues and sponsors to meet our mission. (Button below would link to a form that upon completion would shoot out an email to whoever needs to receive it.)